Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 380.90
+14.00 (3.82%)
At close: Aug 21, 2026
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 41.5 billion as of August 21, 2026. Its market cap has decreased by -1.40% in one year.
Market Cap
41.50B
Enterprise Value
43.06B
Revenue
1.74B
Ranking
n/a
PE Ratio
85.20
Stock Price
380.90
ChartMarket Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 41.50B, an increase of 119,167.16%. That is a compound annual growth rate of 33.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 41.50B | -13.91% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 298.87B |
| Shilpa Medicare | 159.30B |
| Suven Life Sciences | 98.21B |
| IOL Chemicals and Pharmaceuticals | 49.77B |
| Sai Parenteral's | 23.89B |
| NGL Fine-Chem | 18.28B |
| Bajaj HealthCare | 10.84B |
| Anlon Healthcare | 7.59B |